J. Mellors, A. Munoz, and G. J. , Plasma Viral Load and CD4+ Lymphocytes as Prognostic Markers of HIV-1 Infection, Annals of Internal Medicine, vol.126, issue.12, pp.946-54, 1997.
DOI : 10.7326/0003-4819-126-12-199706150-00003

C. Gilks, S. Crowley, and R. Ekpini, The WHO public-health approach to antiretroviral treatment against HIV in resource-limited settings, The Lancet, vol.368, issue.9534, pp.505-515, 2006.
DOI : 10.1016/S0140-6736(06)69158-7

A. Cotter, A. Garcia, M. Duthely, B. Luke, O. Sullivan et al., Is Antiretroviral Therapy during Pregnancy Associated with an Increased Risk of Preterm Delivery, Low Birth Weight, or Stillbirth?, The Journal of Infectious Diseases, vol.193, issue.9, pp.1195-201, 2006.
DOI : 10.1086/503045

C. Thorne, D. Patel, and M. N. , Increased risk of adverse pregnancy outcomes in HIV-infected women treated with higly active antiretroviral therapy in Europe, AIDS, vol.18, pp.2337-2346, 2004.

B. Ingelheim, Important new safety information Re: Clarification of risk factors for severe, life-threatening and fatal hepatotoxicity with VIRAMUNE (nevirapine) 2004. Available from: http://www.fda.gov/medwatch, 2004.

R. Ekpini, J. Nkengasong, T. Sibailly, C. Maurice, C. Adje et al., Changes in plasma HIV-1-RNA viral load and CD4 cell counts, and lack of zidovudine resistance among pregnant women receiving short-course zidovudine, AIDS, vol.16, issue.4, pp.625-655, 2002.
DOI : 10.1097/00002030-200203080-00015

P. Miotti, G. Liomba, G. Dallabetta, D. Hoover, J. Chiphangwi et al., T Lymphocyte Subsets during and after Pregnancy: Analysis in Human Immunodeficiency Virus Type 1-Infected and -Uninfected Malawian Mothers, Journal of Infectious Diseases, vol.165, issue.6, pp.1116-1125, 1992.
DOI : 10.1093/infdis/165.6.1116

M. Temmerman, N. Nagelkerke, J. Bwayo, E. Chomba, J. Ndinya-achola et al., HIV-1 and immunological changes during pregnancy, AIDS, vol.9, issue.9, pp.1057-60, 1995.
DOI : 10.1097/00002030-199509000-00011

F. Dabis, L. Bequet, D. Ekouevi, I. Viho, C. Sakarovitch et al., Field efficacy of zidovudine, lamivudine and single-dose nevirapine to prevent peripartum HIV transmission, AIDS, vol.19, issue.3, pp.309-327, 2005.
URL : https://hal.archives-ouvertes.fr/inserm-00193079

D. Burns, P. Nourjah, H. Minkoff, J. Korelitz, R. Biggar et al., Changes in CD4+ and CD8+ cell levels during pregnancy and post partum in women seropositive and seronegative for human immunodeficiency virus-1, American Journal of Obstetrics and Gynecology, vol.174, issue.5, pp.1461-1469, 1996.
DOI : 10.1016/S0002-9378(96)70589-6

R. Tuomala, D. Shapiro, L. Mofenson, Y. Bryson, M. Culnane et al., Antiretroviral therapy during pregnancy and the risk of an adverse outcome The impact of pregnancy and menopause on CD4 lymphocyte counts in HIV-infected women, N Engl J Med Aids, vol.34616, issue.156, pp.1863-70919, 2002.

B. Carr, C. Parker, J. Madden, J. Macdonald, P. Porter et al., Maternal plasma adrenocorticotropin and cortisol relationships throughout human pregnancy, American Journal of Obstetrics and Gynecology, vol.139, issue.4, pp.416-438, 1981.
DOI : 10.1016/0002-9378(81)90318-5

S. Timmermans, C. Tempelman, M. Godfried, J. Nellen, J. Dieleman et al., Nelfinavir and nevirapine side effects during pregnancy, AIDS, vol.19, issue.8, pp.795-804, 2005.
DOI : 10.1097/01.aids.0000168973.59466.14

F. Mulcahy, E. Wallace, S. Woods, M. Hanlon, S. Clarke et al., CD4 counts in pregnancy do not accurately reflect the need for long-term HAART (abstract 704b), 13th Conference on Retroviruses & Opportunistic Infections, 2006.

. Table, Lymphocytes count and T-lymphocyte CD4+ distribution (absolute count and percentage) and HAART eligibility criteria in HIV-1 infected pregnant women in prepartum and postpartum periods, ANRS 1201/1202 Ditrame Plus study